• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于合成具有HIV gp41糖蛋白免疫显性表位序列的肽中形成二硫键桥的过氧化氢

[Hydrogen peroxide for disulfide bridge formation in the synthesis of peptides with the sequence of the immunodominant epitope of HIV gp41 glycoprotein].

作者信息

Sidorova M V, Kudriavtseva E V, Antopol'skiĭ M L, Pal'keeva M E, Ovchinnikov M V, Bespalova Zh D

出版信息

Bioorg Khim. 1996 Apr;22(4):273-9.

PMID:8768265
Abstract

A simple, rapid, and highly efficient method for intramolecular disulfide formation in tryptophan-containing peptides using hydrogen peroxide was elaborated. Solid phase synthesis of the peptide fragment corresponding to 601-617 sequence of transmembrane gp41 glycoprotein of HIV-1 was performed by Fmoc-technique. Coupling of Fmoc-Asn-OH by DCC-HOBt method was shown to be accompanied by a side reaction of dehydration of asparagine amide function with the formation of side product (22%) containing 3-cyanoalanine residue. This side reaction was not observed, when Fmoc-Asn-OH was coupled in the form of its p-nitrophenyl ester and with HOBt as a catalyst.

摘要

阐述了一种使用过氧化氢在含色氨酸的肽中形成分子内二硫键的简单、快速且高效的方法。采用Fmoc技术进行了HIV-1跨膜糖蛋白gp41 601-617序列对应肽片段的固相合成。通过DCC-HOBt法偶联Fmoc-Asn-OH时,天冬酰胺酰胺官能团脱水形成含3-氰基丙氨酸残基的副产物(22%)的副反应被观察到。当Fmoc-Asn-OH以其对硝基苯酯形式并以HOBt作为催化剂进行偶联时,未观察到该副反应。

相似文献

1
[Hydrogen peroxide for disulfide bridge formation in the synthesis of peptides with the sequence of the immunodominant epitope of HIV gp41 glycoprotein].用于合成具有HIV gp41糖蛋白免疫显性表位序列的肽中形成二硫键桥的过氧化氢
Bioorg Khim. 1996 Apr;22(4):273-9.
2
Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: purification, oxidation without concatamer formation, and selective cleavage.用于工业生产含二硫键肽的重组融合蛋白:纯化、无串联体形成的氧化及选择性切割
Protein Expr Purif. 1998 Apr;12(3):404-14. doi: 10.1006/prep.1997.0844.
3
Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.在gp41免疫显性区域内一种新型1型人类免疫缺陷病毒可中和表位的特性分析
Virology. 2000 Apr 25;270(1):135-45. doi: 10.1006/viro.2000.0269.
4
[Composition of HIV-1 B-epitopes and heterologous T-cell epitopes. I. Maintenance of antigenic properties of HIV-1 B-epitopes].[HIV-1 B表位与异源T细胞表位的组成。I. HIV-1 B表位抗原特性的维持]
Biokhimiia. 1996 Jul;61(7):1221-9.
5
Antigenic properties of phage displayed peptides comprising disulfide-bonded loop of the immunodominant region of HIV-1 gp41.包含HIV-1 gp41免疫显性区域二硫键连接环的噬菌体展示肽的抗原特性。
Immunol Lett. 2004 Sep;95(2):207-12. doi: 10.1016/j.imlet.2004.07.011.
6
[Direct transition of S-acetamidomethyl-protected peptide 593-603 of HIV-2 gp41 into a cyclic disulfide using iodine. Study of side reactions].[利用碘将HIV-2 gp41的S-乙酰氨基甲基保护肽593-603直接转化为环状二硫化物。副反应研究]
Bioorg Khim. 1996 May;22(5):370-5.
7
Collection of phage-peptide probes for HIV-1 immunodominant loop-epitope.用于HIV-1免疫显性环表位的噬菌体肽探针的收集
J Microbiol Methods. 2007 Feb;68(2):225-35. doi: 10.1016/j.mimet.2006.08.001. Epub 2006 Oct 12.
8
[Synthesis of an ethylamide of the cyclic undecapeptide sequence 593-603 of transmembrane glycoprotein gp41 of the human immunodeficiency virus type 2].[人免疫缺陷病毒2型跨膜糖蛋白gp41的环状十一肽序列593 - 603的乙酰胺合成]
Bioorg Khim. 1995 Sep;21(9):675-83.
9
[Directed and spontaneous disulfide bond closure using hydrogen peroxide in the synthesis of endothelins-1 and -3].[在合成内皮素-1和-3过程中使用过氧化氢进行定向和自发二硫键闭合]
Bioorg Khim. 1999 Feb;25(2):107-16.
10
Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.人免疫缺陷病毒1型gp41包膜糖蛋白中一个非中和表位相对于高度保守的中和表位的免疫原性和抗原优势:其缺失导致强烈的中和反应。
Virology. 2000 Jan 5;266(1):66-78. doi: 10.1006/viro.1999.0041.